Background/Aims-By contrast with animal models, in most cases it is not possible to examine the systemic response in patients in the first hours after onset of acute pancreatitis. The aim was to determine whether endoscopic retrograde cholangiopancreaticography (ERP)-induced pancreatitis can be used as a human model for the study ofcytokine release and acute phase response in the first hours of the disease. Patients and methods-Seventy consecutive patients undergoing ERP for different reasons were prospectively evaluated by sampling blood before and 0, 1, 4, 12, 24, and 48 hours after ERP and, in patients who developed an acute post-ERP pancreatitis, daily until C reactive protein (CRP) was within normal range. A post-ERP pancreatitis was defined as a threefold increase of amylase or lipase and at least two of the clinical symptoms: abdominal pain, nausea, vomiting, and peritonism during 24 hours after ERP. Results-Nine out of 70 patients developed an acute pancreatitis. Cytokines and other biochemical variables were measured in those nine and in 34 patients out of the 61 not developing pancreatitis. In the nine patients amylase and lipase increased within the first hour after ERP with maximum values between four and 12 hours. Interleukin-6 increased to maximal concentrations after 24-48 hours and the highest CRP concentrations were found 72 hours after ERP. Tumour necrosis factor did not change. Conclusion-Post-ERP pancreatitis is an ideal model in which to examine the initial cytokine and acute phase response in the first hours after the initiation of the disease.
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The pathophysiology and mechanism of acute pancreatitis are complex and humoral and cellular interactions are involved in the network of the proteolytic induced pathomechanism.
Acute pancreatitis ranges from mild to extremely severe disease with multiple organ failure and fatal outcome.' Once an acute pancreatitis has developed it is important to differentiate between patients with mild disease and those with a high risk for a severe outcome.2 Several prognostic indices mainly based on laboratory data -for example, the scoring system of Ranson et al3 -have been suggested as methods of detecting high risk patients. Granulocyte elastase,4 5 protease inhibitors,6 acute phase proteins such as C reactive protein (CRP),7 8 9 or cytokines such as interleukin 6 (IL-6)'1-12 are potential serum markers to assess the prognosis in acute pancreatitis. We have also shown a close relation between the concentrations and the time courses of serum IL-6 and CRP, suggesting that during this inflammatory condition IL-6 is the main inducer of acute phase protein synthesis in humans.'0 A major disadvantage of all studies examining the pathophysiology of acute pancreatitis in humans is the delay between the start of symptoms and admission to hospital. Therefore no data during the initiation phase of acute pancreatitis are available to describe exactly the time course of cytokine release and acute phase response in humans.
The aetiology of acute pancreatitis can be very different, but the concurrent acute phase response is uniform and is dependent on the severity of the disease. Using endoscopic retrograde cholangiopancreaticography (ERP) induced pancreatitis as a model for early acute pancreatitis it was possible for the first time to describe the acute phase response of acute pancreatitis in humans from the onset of the disease. Acute pancreatitis is a major complication of ERP. An increase of amylase after ERP is found in about 250/o-75% of patients.'3-'6 Increases in pancreatic enzymes after ERP that are not associated with symptoms are generally considered unimportant. '7 The frequency of post-ERP pancreatitis in most prospective studies is [5] [6] [7] [8] [9] [10] (extreme ranges 0 0-39 0)%, depending on several factors including operator experience, presence of acinar filling, the volume and osmolarity of the contrast medium, '8 All patients were assessed clinically daily for at least 48 hours; the nine patients with a post-ERP pancreatitis were assessed until they were free of symptoms, but at least for one week.
LABORATORY METHODS Blood samples were taken before ERP and 0, 1, 4, 12, 24, and 48 hours after ERP in all 70 patients, and in patients who developed an acute post-ERP pancreatitis, daily until CRP was within normal range. Samples from 43 patients were used for analysis while the 27 with initially raised CRP were discarded.
Amylase was measured by an enzymatic colour test (Boehringer Mannheim GmbH Diagnostica, Mannheim, Germany) with normal values <120 U/1. Lipase was determined by turbidimetry using UV light (Boehringer) . Normal values were set at <190 U/1. CRP was measured using an immunological turbidimetric test (Boehringer) with normal values of <5 mg/l. The serum concentrations of IL-6 were measured by an enzyme linked immunosorbent assay (ELISA; Quantikine R and D Systems Inc, Minneapolis, USA). The minimum detectable dose was 0 70 pg/ml, the normal serum IL-6 concentration was < 10 pg/ml, and the coefficient of variation (CV) was <4-4%. Tumour necrosis factor (TNF) was also measured by an ELISA (Medgenix, Ratingen, Germany) with a minimum detectable concentration of 3 pg/ml and a CV <5-2% (a normal serum TNF concentration of <20 pg/ml). DATA 
ANALYSIS
Data are expressed as median with ranges. Correlations were calculated by using linear regression grades and estimating the coefficient of correlation. Statistical analysis was by two tailed Mann-Witney U test using the statistical software of Sigma Stat (Version 1X0, Jandel Corporation). Significance was set at p<0*05.
Results
Nine of the 70 patients (12X9%) developed an acute pancreatitis as defined above. In eight patients the pancreatitis was mild and one patient developed a severe necrotising pancreatitis. One of these nine patients had signs of a chronic pancreatitis on ERP whereas the others showed a normal pancreatogram. The remaining 34 patients used for analysis had pancreatic tumour (n=5), chronic pancreatitis (n=10), and normal findings (n=19) in ERP (Fig 1) . Patients with post-ERP pancreatitis were all treated as inpatients and were in hospital for a median of 13 (range [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] days.
LIPASE, AMYLASE, CRP, IL-6, AND TNF AFTER ERP
Peak values for lipase and amylase occurred one to four hours after ERP and were within normal ranges after 24-48 hours for the 27 patients with normal ERP, chronic pancreatitis, and pancreatic tumours not developing pancreatitis, whereas in those patients developing an acute post-ERP pancreatitis lipase and amylase were within normal ranges after 48-72 hours respectively (96 hours for the patient with necrotising pancreatitis) (Fig 2) .
In five out of 29 patients with a normal pancreatogram and no signs of ERP induced pancreatitis IL-6 increased without an increase in CRP. All patients with post-ERP pancreatitis (n=9) first developed an increase in IL-6 followed by an increase in CRP. However, the five patients with pancreatic tumours and no ERP induced pancreatitis showed slightly increased IL-6 (<20 pg/ml) and CRP (< 10 mg/ 1) values which did not change significantly after ERP.
In those patients developing post-ERP pancreatitis, IL-6 concentrations increased significantly between 12-48 hours and peaked at 48 hours whereas CRP peaked 72 hours after ERP. TNF showed no changes (Fig 3 and   Fig 4A) .
For the patient with necrotising pancreatitis IL-6 (565-2 pg/ml) peaked by 24 hours after ERP and CRP (227T0 mg/l) peaked 48 hours later; TNF did not change over time (Fig 4B) . Figure 5 shows the peak values of IL-6 and CRP for all patients.
Maximal serum concentrations of IL-6 at days 1-7 correlated with the maximal serum concentrations of CRP in all patients with post-ERP pancreatitis (r=0-83; p=0 00199; Fig 6) . (Table) .
All patients with a post-ERP pancreatitis except one had a more than threefold increase of lipase (median 6-5 (range 1'3 to 43-fold increase) immediately after ERP (time 0), which was significantly higher than in patients with post-ERP pancreatitis (p=0-0145; Fig 2) . Amylase also showed a significant increase immediately after ERP in patients with post-ERP pancreatitis compared with the remaining patients (p=0.0026). Figure 5 : Peak serum concentrations of (A) IL-6 (normal <10 pg/ml) and (B) CRP (normal <5 mg/l) after ERP in patients with and without post-ERPpancreatitis. ARepresents patient with a necrotisingpancreatitis. -Represents median IL-6 and CRP concentrations. There is a significant difference between CRP and IL-6 serum concentrations ofpatients with post-ERPpancreatitis and patients with normal pancreatogram (p<00001 and p<00001 respectively) or chronic pancreatitis (p<00001 and p<00001 respectively) or pancreatic tumour (NS and p<00026).
PREDICTIVE VALUE OF IL-6 FOR DEVELOPMENT OF PANCREATITIS
In all patients with acute post-ERP pancreatitis * an increased IL-6 value was followed by an increased CRP. However, five out of the 29 * patients with no signs of a post-ERP pancreatitis had increased IL-6 concentrations (mean 29-2 (SD 6&4 pg/ml) which were not followed by a CRP peak (mean 3-5 (SD 0 5 mg/l). The remaining 24 patients did not have increased IL-6 or CRP (Fig 6) . 
Discussion
It has been proposed that in acute pancreatitis there is an activation of inflammatory cells resulting in the release of inflammatory mediators responsible for a severe course of the disease."9 In a previous reportl we provided evidence that serum IL-6 concentrations precede acute phase response and reflect severity in acute pancreatitis.
However, neither this study nor other data describe the early onset of acute pancreatitis with regard to clinical symptoms and to the the very beginning of acute pancreatitis. In all patients developing an acute pancreatitis IL-6 release was followed by a CRP increase 24-48 hours later (Fig 3) . While the patient with the necrotising pancreatitis had the IL-6 peak by 24 hours (Fig 3B) , in the patients with mild pancreatitis this was delayed to 48 hours after ERP (Fig 3A) . Therefore it is possible that the severity of the disease is not only reflected by higher but also earlier peaking IL-6 serum concentrations. These findings contrast with those of Viedma et all' and Heath et all2 who found increased IL-6 serum concentrations in patients with necrotising pancreatitis, but not in patients with mild pancreatitis. This may be due to a more sensitive EILSA for IL-6 measurement, with a detection limit of 0-7 pg/ ml in our study compared with 150 pg/ml in earlier studies. Furthermore we showed, using this more sensitive ELISA, a similar IL-6 release in patients with mild pancreatitis compared with a patient with necrotising pancreatitis, but with a delayed and smaller IL-6 peak. More patients with severe and mild forms of pancreatitis need to be studied to confirm this. In all patients the CRP peak occurred between 48-72 hours after ERP.
Considering a time delay offour to five hours between pancreatic injury by ERP and first clinical symptoms we found an earlier peak of IL-6 than did Viedma et al, " who measured the IL-6 peak 48-72 hours after the first clinical symptoms, and Heath et all2 found a peak after 36 hours in patients with necrotising pancreatitis. However, the time delay between IL-6 peak and CRP peak was nearly the same as our study. Other groups2' 22 examined the IL-6 response after elective surgical interventions and found an early peak of IL-6, within 24 hours after operation. This is similar to our findings, probably because these groups could also determine the time of organ injury exactly.
By contrast with other reports, some of the patients with mild pancreatitis had CRP concentrations above 120 mg/l. This might be because more samples were measured than is usual in clinical practice.
We Figure 6 shows a correlation between IL-6 and CRP in patients with post-ERP pancreatitis, so it is possible. The fact that in five patients IL-6 but not CRP was raised indicates that there might be a threshold concentration of IL-6 for induction of CRP procuction rather than other factors influencing CRP release in these patients. It is known from both animal and human studies that IL-6 is the main inducer of acute phase protein synthesis in hepatocytes.10
The importance of TNF in acute pancreatitis is controversial. Our findings that TNF was not increased in our patients, mostly with mild pancreatitis, accord with other reports. Increases of TNF have mostly been described in cases of severe acute pancreatitis.23 24 Pajaanen et al25 found the highest TNF values on the first day of admission, but these exceeded the detectable concentration in only 9% of the patients. Norman et al found a correlation between severity of pancreatic damage and TNF concentration,26 which might explain why no increases in TNF could be measured in our patients.
In conclusion, our data showed that post-ERP pancreatitis is an ideal model to examine the early onset of acute pancreatitis in humans. We have shown for the first time that injury to the pancreas is followed with a relatively uniform delay by clinical symptoms and that IL-6 release appears earlier than previous studies have suggested from retrospective analysis. However, there is agreement in the time delay between IL-6 and CRP release. The pattern of release of IL-6 seems to be similar for mild and severe pancreatitis but, with a difference in time of peak and absolute IL-6 serum concentrations. Release of IL-6 is not always followed by an increase in CRP; however, in those patients with an ERP induced pancreatitis all patients had raised IL-6 values followed by increased CRP values. 
